Amsterdam-based LUMICKS signs €20 million venture debt with EIB to accelerate the development and launch of its new product, designed to advance immunotherapy development for cancer research. LUMICKS’ next generation high-throughput cell avidity platform aims to transform the drug discovery process by replacing traditional screening methods, expediting development for life-saving treatments, and improving reliability in […]
The San Francisco-based company with an R&D facility in Bilbao has also unveiled its Platforma.bio Software Development Kit, transforming how biologists analyze genomic data to drive drug discovery and advance adjacent fields in medicine. This latest financing bolsters the company’s efforts to transform computational biology on a global scale and empower researchers with innovative tools […]
MaxCyte Appoints Ali Soleymannezhad as Chief Commercial Officer Rockville, MD – MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bioprocessing applications, today announced the appointment of Ali Soleymannezhad as Chief Commercial Officer, effective as of September 11, 2024. In […]
Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs for genetic disorders. Novel digestion enzymes deliver complete RNA sequence coveragei for more confident characterization, while new LC-MS-grade reagents increase sensitivity and improve detection accuracy of RNA components.ii New waters_connect™ MAP Sequence […]
CALIBRE SCIENTIFIC ACQUIRES MRC, A US-BASED MANUFACTURER OF REAGENTS FOR THE ISOLATION AND ANALYSIS OF RNA AND DNA Calibre Scientific has acquired Molecular Research Center, Inc., Founded in 1989 and based in Ohio, USA, MRC is recognized for its expertise in RNA isolation technologies. MRC develops and manufactures reagents and kits used in molecular biology, biotechnology, […]
CALIBRE SCIENTIFIC ACQUIRES INVITECH, A UK-BASED SUPPLIER OF IN-VITRO DIAGNOSTICS AND RESEARCH KITS Calibre Scientific has acquired Invitech Ltd., a UK-based supplier of in-vitro diagnostics and research kits to clinical laboratories, CRO’s, public institutions and universities in the British Isles. Their products include HIV/HCV test kits (including PoC tests), pregnancy tests, ELISA kits, Lyme Disease test […]
Combined single-cell spatial genomics and multiplex proteomic profiling technologies position merged company to accelerate discoveries in foundational and clinical research CAMBRIDGE, Mass. – Vizgen, Inc., a life science company dedicated to improving human health by visualizing single-cell spatial genomics information, and Ultivue, Inc., a market leader in multiplex proteomic biomarker detection and advanced AI-driven spatial tissue […]
Designed tomakenext-generation sequencing accessible to more labs With room-temperature kit storage and shipping, Illumina’s newest sequencers remove barriers to enable more insights and discoveries SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today unveiled its MiSeq™ i100 Series of sequencing systems, delivering unparalleled benchtop speed and simplicity […]
Now Launching in US its patent pending, first magnetic bead-based Short Fragment Depletor – 10 High Throughput (SFD-10HT) kit for long Read Sequencing technologies GAITHERSBURG, Md. — MagBio Genomics, Inc., a company that focuses on magnetic bead-based nucleic acids sample preparation products for sequencing and molecular diagnostics, announces the global launch of its patent-pending Short […]
SEATTLE — Phase Genomics, Inc., a leading innovator at the forefront of genomics technology development, today announced the appointment of David Shoultz, PhD, MBA as the company’s first Chief Business Officer. A strategic addition to the executive suite, Shoultz will drive growth as Phase Genomics accelerates market awareness and its work to amplify the impact […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
